Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis

NCT: NCT05625113 · COMPLETED

NCT IDNCT05625113
StatusCOMPLETED
Start Date2023-01-17
Completion2023-07-23
SponsorUniversity Hospital, Toulouse (OTHER)
First posted
Last updated

Brief Summary

The study is focused on the evaluation of the feasibility, usability, acceptability, tolerance, functional impact and organizational impact of the use of a wearable prehension neuroprosthesis (innovative medical device) at home, with triggering methods specifically adapted to a population of hemiparetic post-stroke subjects. The main objective is to describe the overall therapeutic compliance represented by the number of uses of the neuroprosthesis in real-life situations.

Frequently Asked Questions

What is Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis?

Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis is a clinical trial registered under NCT05625113. Current status: COMPLETED.

What is the status of NCT05625113?

The current status of NCT05625113 (Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis) is: COMPLETED.

When did Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis start?

Wearable Grasping Neuroprosthesis Used at Home in Subjects With Post-stroke Hemiparesis started on 2023-01-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.